These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 9481788)
21. Ontogenetic expression of D2 dopamine receptor mRNA in rat corpus striatum. Chen JF; Weiss B Brain Res Dev Brain Res; 1991 Nov; 63(1-2):95-104. PubMed ID: 1665109 [TBL] [Abstract][Full Text] [Related]
22. Increased superoxide generation is associated with decreased superoxide dismutase activity and mRNA expression in placental trophoblast cells in pre-eclampsia. Wang Y; Walsh SW Placenta; 2001; 22(2-3):206-12. PubMed ID: 11170825 [TBL] [Abstract][Full Text] [Related]
23. Decreased placental GCM1 (glial cells missing) gene expression in pre-eclampsia. Chen CP; Chen CY; Yang YC; Su TH; Chen H Placenta; 2004 May; 25(5):413-21. PubMed ID: 15081636 [TBL] [Abstract][Full Text] [Related]
24. Pre-eclampsia and expression of heparin-binding EGF-like growth factor. Leach RE; Romero R; Kim YM; Chaiworapongsa T; Kilburn B; Das SK; Dey SK; Johnson A; Qureshi F; Jacques S; Armant DR Lancet; 2002 Oct; 360(9341):1215-9. PubMed ID: 12401248 [TBL] [Abstract][Full Text] [Related]
25. D2 dopamine receptor gene expression in the rat striatum during ontogeny: an in situ hybridization study. Guennoun R; Bloch B Brain Res Dev Brain Res; 1991 May; 60(1):79-87. PubMed ID: 1680582 [TBL] [Abstract][Full Text] [Related]
26. Effects of dopamine and melatonin on the regulation of the PIT-1 isotype, placental growth hormone and lactogen gene expressions in the rat placenta. Lee CK; Kang HS; Lee BJ; Kang HM; Choi WS; Kang SG Mol Cells; 1999 Dec; 9(6):646-51. PubMed ID: 10672932 [TBL] [Abstract][Full Text] [Related]
27. The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto-maternal interface. Han VK; Bassett N; Walton J; Challis JR J Clin Endocrinol Metab; 1996 Jul; 81(7):2680-93. PubMed ID: 8675597 [TBL] [Abstract][Full Text] [Related]
28. 11beta-Hydroxysteroid dehydrogenase activity in pregnancies complicated by hydatidiform mole. Muneyyrici-Delale O; Nacharaju VL; Sidell J; Neil G; Karacan M; Camilien L; Temkin S; Abulafia O Am J Reprod Immunol; 2006 Jun; 55(6):415-9. PubMed ID: 16674598 [TBL] [Abstract][Full Text] [Related]
29. A role for noradrenaline in pre-eclampsia: towards a unifying hypothesis for the pathophysiology. Manyonda IT; Slater DM; Fenske C; Hole D; Choy MY; Wilson C Br J Obstet Gynaecol; 1998 Jun; 105(6):641-8. PubMed ID: 9647155 [TBL] [Abstract][Full Text] [Related]
30. Increased adrenomedullin protein content and mRNA expression in human fetal membranes but not placental tissue in pre-eclampsia. Al-Ghafra A; Gude NM; Brennecke SP; King RG Mol Hum Reprod; 2006 Mar; 12(3):181-6. PubMed ID: 16517613 [TBL] [Abstract][Full Text] [Related]
31. Placental expression of VEGF family mRNA in adverse pregnancy outcomes. Andraweera PH; Dekker GA; Laurence JA; Roberts CT Placenta; 2012 Jun; 33(6):467-72. PubMed ID: 22386962 [TBL] [Abstract][Full Text] [Related]
32. Epigenetic regulation of STAT5A and its role as fetal DNA epigenetic marker during placental development and dysfunction. Rahat B; Thakur S; Bagga R; Kaur J Placenta; 2016 Aug; 44():46-53. PubMed ID: 27452437 [TBL] [Abstract][Full Text] [Related]
33. Increased placental iron regulatory protein-1 expression in diabetic pregnancies complicated by fetal iron deficiency. Georgieff MK; Berry SA; Wobken JD; Leibold EA Placenta; 1999 Jan; 20(1):87-93. PubMed ID: 9950149 [TBL] [Abstract][Full Text] [Related]
34. Fibroblast growth factor-2 and fibroblast growth factor receptor-1 mRNA expression and peptide localization in placentae from normal and diabetic pregnancies. Arany E; Hill DJ Placenta; 1998; 19(2-3):133-42. PubMed ID: 9548179 [TBL] [Abstract][Full Text] [Related]
35. Glycogen metabolism in vesicles of hydatidiform mole in vitro. Maeyama M; Matsuo I; Nakahara K Fertil Steril; 1977 Aug; 28(8):851-5. PubMed ID: 407107 [TBL] [Abstract][Full Text] [Related]
36. The expression of placental proteoglycans in pre-eclampsia. Chui A; Murthi P; Brennecke SP; Ignjatovic V; Monagle PT; Said JM Gynecol Obstet Invest; 2012; 73(4):277-84. PubMed ID: 22516801 [TBL] [Abstract][Full Text] [Related]
37. Detection of placental growth hormone variant and chorionic somatomammotropin ribonucleic acid expression in human trophoblastic neoplasms by reverse transcriptase-polymerase chain reaction. Lytras A; Bock ME; Dodd JG; Cattini PA Endocrinology; 1994 Jun; 134(6):2461-7. PubMed ID: 7515000 [TBL] [Abstract][Full Text] [Related]
38. The regional expression of insulin-like growth factor II (IGF-II) and insulin-like growth factor binding protein-1 (IGFBP-1) in the placentae of women with pre-eclampsia. Gratton RJ; Asano H; Han VK Placenta; 2002 Apr; 23(4):303-10. PubMed ID: 11969341 [TBL] [Abstract][Full Text] [Related]
39. SUMO-4: A novel functional candidate in the human placental protein SUMOylation machinery. Baczyk D; Audette MC; Drewlo S; Levytska K; Kingdom JC PLoS One; 2017; 12(5):e0178056. PubMed ID: 28545138 [TBL] [Abstract][Full Text] [Related]
40. Cotreatment with the kappa opioid agonist U69593 enhances locomotor sensitization to the D2/D3 dopamine agonist quinpirole and alters dopamine D2 receptor and prodynorphin mRNA expression in rats. Perreault ML; Graham D; Scattolon S; Wang Y; Szechtman H; Foster JA Psychopharmacology (Berl); 2007 Nov; 194(4):485-96. PubMed ID: 17619861 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]